Cargando…

Consistency of Safety and Efficacy of New Oral Anticoagulants across Subgroups of Patients with Atrial Fibrillation

AIMS: The well-known limitations of vitamin K antagonists (VKA) led to development of new oral anticoagulants (NOAC) in non-valvular atrial fibrillation (NVAF). The aim of this meta-analysis was to determine the consistency of treatment effects of NOAC irrespective of age, comorbidities, or prior VK...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lega, Jean-Christophe, Bertoletti, Laurent, Gremillet, Cyrielle, Chapelle, Céline, Mismetti, Patrick, Cucherat, Michel, Vital-Durand, Denis, Laporte, Silvy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951387/ https://www.ncbi.nlm.nih.gov/pubmed/24622012 http://dx.doi.org/10.1371/journal.pone.0091398

Ejemplares similares

Assessment of non-inferiority with meta-analysis: example of hypofractionated radiation therapy in breast and prostate cancer
por: Trone, Jane-Chloé, et al.
Publicado: (2020)

Meta-regression of randomized control trials with antithrombotics: weak correlation between net clinical benefit and all cause-mortality
por: Kilo, Roubi, et al.
Publicado: (2021)

Extended anticoagulation for the secondary prevention of venous thromboembolic events: An updated network meta-analysis
por: Mai, Vicky, et al.
Publicado: (2019)

Reasons Influencing Long-Term Anticoagulant Treatment Beyond 6 Months for Cancer-Associated Thrombosis in USCAT, A 432-Patient Retrospective Non-Interventional Study
por: Plaisance, Ludovic, et al.
Publicado: (2021)

Management of Cancer-Associated Thrombosis in France: A National Survey among Vascular Disease and Supportive Care Specialists
por: Mahé, Isabelle, et al.
Publicado: (2022)

Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014)

Long-Term Treatment of Cancer-Associated Thrombosis (CAT) Beyond 6 Months in the Medical Practice: USCAT, a 432-Patient Retrospective Non-Interventional Study
por: Mahé, Isabelle, et al.
Publicado: (2020)

Tissue factor pathway inhibitor for prediction of placenta-mediated adverse pregnancy outcomes in high-risk women: AngioPred study
por: Di Bartolomeo, Aurélie, et al.
Publicado: (2017)

Prevalence of oral anticoagulation in atrial fibrillation
por: Bartholomay, Eduardo, et al.
Publicado: (2014)

Anticoagulation in atrial fibrillation: the present and the future
por: Dweck, Marc R, et al.
Publicado: (2012)

Anticoagulation for atrial fibrillation in active cancer
por: Farmakis, Dimitrios, et al.
Publicado: (2022)

Non-Vitamin K Oral Anticoagulants for Stroke Prevention in Special Populations with Atrial Fibrillation
por: Bisson, Arnaud, et al.
Publicado: (2017)

Atrial Fibrillation Ablation without Interruption of Anticoagulation
por: Santangeli, Pasquale, et al.
Publicado: (2011)

The new oral anticoagulants in atrial fibrillation: an update
por: Verheugt, F. W. A.
Publicado: (2013)

Newer Anticoagulants for Non-Valvular Atrial Fibrillation
por: Harburger, Joseph M., et al.
Publicado: (2012)

MRI Screening for Chronic Anticoagulation in Atrial Fibrillation
por: Fisher, Mark
Publicado: (2013)

Satisfaction with oral anticoagulants in patients with atrial fibrillation
por: Suárez Fernández, Carmen, et al.
Publicado: (2018)

Anticoagulant Therapy for Frail Patients with Atrial Fibrillation
por: Hori, Hiroshi, et al.
Publicado: (2021)

Secondary Precipitants of Atrial Fibrillation and Anticoagulation Therapy
por: Ko, Darae, et al.
Publicado: (2021)

Anticoagulation in patients with atrial fibrillation and liver cirrhosis
por: Karapedi, Eleni, et al.
Publicado: (2022)

Prior Anticoagulation in Patients with Ischemic Stroke and Atrial Fibrillation
por: Meinel, Thomas R., et al.
Publicado: (2020)

Impact of wearable device-based interventions with feedback for increasing daily walking activity and physical capacities in cardiovascular patients: a systematic review and meta-analysis of randomised controlled trials
por: Heizmann, Anne-Noëlle, et al.
Publicado: (2023)

Anticoagulation for Atrial Fibrillation in Cirrhosis of the Liver: Are Low‐Dose Non‐Vitamin K Oral Anticoagulants a Reasonable Alternative to Warfarin?
por: Gallagher, Celine, et al.
Publicado: (2019)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022)

Patterns of Anticoagulation Use in Patients With Cancer With Atrial Fibrillation and/or Atrial Flutter
por: Fradley, Michael G., et al.
Publicado: (2020)

Anticoagulation in Cancer Patients With Atrial Fibrillation or Atrial Flutter: Are There Gaps in Care?
por: Russo, Andrea M.
Publicado: (2020)

Correction: Tissue factor pathway inhibitor for prediction of placenta-mediated adverse pregnancy outcomes in high-risk women: AngioPred study
por: Di Bartolomeo, Aurélie, et al.
Publicado: (2017)

Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
por: Turpie, Alexander GG
Publicado: (2014)

The Italian START-Register on Anticoagulation with Focus on Atrial Fibrillation
por: Antonucci, Emilia, et al.
Publicado: (2015)

Novel oral Anticoagulants in Non-Valvular Atrial Fibrillation
por: da Silva, Rose M.F.L.
Publicado: (2014)

The Influence of Socioeconomic Status on Selection of Anticoagulation for Atrial Fibrillation
por: Sholzberg, Michelle, et al.
Publicado: (2016)

Physician's Fear of Anticoagulant Therapy in Nonvalvular Atrial Fibrillation
por: Sen, Souvik, et al.
Publicado: (2014)

Characterization of patients with atrial fibrillation not treated with oral anticoagulants
por: Johansson, Cecilia, et al.
Publicado: (2014)

Oral Anticoagulants for Atrial Fibrillation Patients with Active Cancer
por: Kim, Do Young, et al.
Publicado: (2018)

Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation
por: Giustozzi, Michela, et al.
Publicado: (2019)

Novel Oral Anticoagulants in Atrial Fibrillation: Update on Apixaban
por: Mezue, Kenechukwu, et al.
Publicado: (2017)

Anticoagulation Management in Patients with Pacemaker-Detected Atrial Fibrillation
por: Poposka, Lidija, et al.
Publicado: (2016)

Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
por: Schäfer, Andreas, et al.
Publicado: (2020)

Anticoagulation in Patients with Atrial Fibrillation and Coronary Artery Disease
por: Alkindi, Fahad Abdullah, et al.
Publicado: (2020)

Oral Anticoagulation and Antiarrhythmic Drug Therapy for Atrial Fibrillation
por: Reiffel, James A.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_d56461nm5dklb22oenk4ijud7f